UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease

Journal of clinical oncology, 2011-06, Vol.29 (18), p.2481-2486

2011

Volltextzugriff (PDF)

Immunotherapy-induced endocrinopathies: assessment, management and monitoring

Therapeutic Advances in Endocrinology and Metabolism, 2019, Vol.10, p.2042018819896182

2019

Volltextzugriff (PDF)

British HIV Association guidelines for HIV‐associated malignancies 2014

HIV medicine, 2014-03, Vol.15, p.1-92

2014

Volltextzugriff (PDF)

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer

Journal of thoracic oncology, 2016-07, Vol.11 (7), p.1029-1039

2016

Volltextzugriff (PDF)

Association of primary and community care services with emergency visits and hospital admissions at the end of life in people with cancer: a retrospective cohort study

BMJ open, 2022-02, Vol.12 (2), p.e054281-e054281

2022

Volltextzugriff (PDF)

Brief communication: rituximab in HIV-associated multicentric Castleman disease

Annals of internal medicine, 2007-12, Vol.147 (12), p.836

2007

Volltextzugriff (PDF)

Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand

International immunology, 2008-04, Vol.20 (4), p.525-534

2008

Volltextzugriff (PDF)

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

Oncogene, 2015-04, Vol.34 (16), p.2138-2144

2015

Volltextzugriff (PDF)

Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

JAMA network open, 2022-02, Vol.5 (2), p.e220130

2022

Volltextzugriff (PDF)

The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma

AIDS (London), 2009-08, Vol.23 (13), p.1701-1706

2009

Volltextzugriff (PDF)

Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma

International journal of cancer, 2004-01, Vol.108 (3), p.473-474

2004

Volltextzugriff (PDF)

HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?

Journal of acquired immune deficiency syndromes (1999), 2004-12, Vol.37 (5), p.1563

2004

Volltextzugriff (PDF)

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

The lancet oncology, 2020-10, Vol.21 (10), p.1309-1316

2020

Volltextzugriff (PDF)

A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy

Annals of internal medicine, 2005-08, Vol.143 (4), p.265

2005

Volltextzugriff (PDF)

Lung cancer treatment during a pandemic: how have multi-disciplinary teams changed?

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S18

2021

Volltextzugriff (PDF)

Increased emergency presentation of new lung cancer diagnoses and less treatment: a COVID legacy

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S20

2021

Volltextzugriff (PDF)

Pleomorphic lung carcinoma – a rare response to a rare tumour

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S76

2021

Volltextzugriff (PDF)

27 Characteristics of lung cancer diagnosed through a Rapid Diagnostic Clinic

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107588, Article 107588

2024

Volltextzugriff (PDF)

95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107656, Article 107656

2024

Volltextzugriff (PDF)

Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis

Radiotherapy and oncology, 2024-06, Vol.195, p.110266-110266, Article 110266

2024

Volltextzugriff (PDF)

Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S46

2021

Volltextzugriff (PDF)

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK

AIDS (London), 2013-06, Vol.27 (10), p.1603-1613

2013

Volltextzugriff (PDF)

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

Blood, 2011-07, Vol.118 (2), p.271-275

2011

Volltextzugriff (PDF)

84 National Real World Study of Adjuvant Osimertinib in Resected EGFR Mutated Lung Cancer

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107645, Article 107645

2024

Volltextzugriff (PDF)

66 - Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S32-S32

2022

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(21)
Female
(15)
Male
(15)
Adult
(12)
Middle Aged
(12)
Aged
(11)
Oncology
(11)
Infectious Diseases
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Cancer
(7)
Human Viral Diseases
(7)
Immunology
(7)
Prospective Studies
(7)
Viral Diseases
(7)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(7)
Antiretroviral Therapy, Highly Active
(6)
Hiv Infections - Complications
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(9)
Aids
(2)
Annals Of Internal Medicine
(2)
Blood
(2)
Hiv Medicine
(2)
Journal For Immunotherapy Of Cancer
(2)
Journal Of Acquired Immune Deficiency Syndromes
(2)
Bmj Open
(1)
Ecancermedicalscience
(1)
International Immunology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease

Immunotherapy-induced endocrinopathies: assessment, management and monitoring

British HIV Association guidelines for HIV‐associated malignancies 2014

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer

Association of primary and community care services with emergency visits and hospital admissions at the end of life in people with cancer: a retrospective cohort study

Brief communication: rituximab in HIV-associated multicentric Castleman disease

Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma

Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma

HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy

Lung cancer treatment during a pandemic: how have multi-disciplinary teams changed?

Increased emergency presentation of new lung cancer diagnoses and less treatment: a COVID legacy

Pleomorphic lung carcinoma – a rare response to a rare tumour

27 Characteristics of lung cancer diagnosed through a Rapid Diagnostic Clinic

95 Lorlatinib in advanced ALK-rearranged NSCLC – real-world experience in a UK population

Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis

Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

84 National Real World Study of Adjuvant Osimertinib in Resected EGFR Mutated Lung Cancer

66 - Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data

Suchergebnisse filtern